CLINICAL PROFILE OF BIOPSY-PROVEN IDIOPATHIC MYOCARDITIS

被引:22
|
作者
RAMAMURTHY, S [1 ]
TALWAR, KK [1 ]
GOSWAMI, KC [1 ]
SHRIVASTAVA, S [1 ]
CHOPRA, P [1 ]
BROOR, S [1 ]
MALHOTRA, A [1 ]
机构
[1] ALL INDIA INST MED SCI,DEPT CARDIOL,NEW DELHI 110029,INDIA
关键词
BIOPSY; MYOCARDITIS;
D O I
10.1016/0167-5273(93)90119-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We studied 20 patients in detail (age: 27 months to 45 years, mean 22 years; 15 males, 5 females) of idiopathic myocarditis histologically confirmed by endomyocardial biopsy. None of these patients had evidence of active or previous rheumatic fever. The commonest mode of presentation was congestive heart failure (16 patients) followed by arrhythmias (seven patients - five of whom had associated congestive heart failure) and chest pain resembling myocardial infarction (two patients). Ten patients had a history of preceding upper respiratory infection. Only one of these patients had a significant rising serum titre for Coxsackie B3 virus. Throat and rectal swabs for virus culture were negative in all patients. The electrocardiogram was abnormal in all patients, with a prolonged corrected QT-interval being the commonest abnormality (14 patients). Serial electrocardiographic patterns of evolving myocardial infarction occurred in three patients. Echocardiographic left ventricular end diastolic dimension (4.15 +/- 1.01 cm/m2) and end systolic dimension (3.37 +/- 1.03 cm/m2) were increased in 15 of the 18 patients studied. Pericardial involvement occurred in only one patient. Radionuclide ventriculography showed a reduced left ventricular ejection fraction (< 50%) in 17 patients, global hypokinesia in 12 patients and regional wall motion abnormalities in five patients. Left ventricular and right ventricular end diastolic pressures were elevated in 15 and 11 patients. respectively.
引用
收藏
页码:225 / 232
页数:8
相关论文
共 50 条
  • [31] Predictors of acute exacerbation in biopsy-proven idiopathic pulmonary fibrosis
    Kishaba, Tomoo
    Hozumi, Hironao
    Fujisawa, Tomoyuki
    Nei, Yuichiro
    Enomoto, Noriyuki
    Sugiura, Hiroaki
    Kitani, Masashi
    Suda, Takafumi
    RESPIRATORY INVESTIGATION, 2020, 58 (03) : 177 - 184
  • [32] Cardiac Magnetic Resonance Imaging in Biopsy-proven Myocarditis: Lack of Relationship With Clinical Presentation and Viral Etiology
    Marra, Martina Perazzolo
    Angelini, Annalisa
    Cacciavillani, Luisa
    Corbetti, Francesco
    De Lazzari, Manuel
    Zilio, Filippo
    Ramondo, Angelo Bruno
    Tarantini, Giuseppe
    Boffa, Giovanni Maria
    Thiene, Gaetano
    Iliceto, Sabino
    Caforio, Alida L. P.
    CIRCULATION, 2009, 120 (18) : S336 - S336
  • [33] Clinical characteristics and outcome of biopsy-proven myocarditis in children - Results of the German prospective multicentre registry "MYKKE "
    Seidel, Franziska
    Opgen-Rhein, Bernd
    Rentzsch, Axel
    Boehne, Martin
    Wannenmacher, Bardo
    Boecker, Dorothee
    Reineker, Katja
    Grafmann, Maria
    Wiegand, Gesa
    Hecht, Tobias
    Kiski, Daniela
    Fischer, Marcus
    Papakostas, Konstantin
    Ruf, Bettina
    Kramp, Jennifer
    Khalil, Marcus
    Kaestner, Michael
    Steinmetz, Michael
    Fischer, Gunther
    Oezcan, Sevinc
    Freudenthal, Noa
    Schweigmann, Ulrich
    Hellwig, Regina
    Pickardt, Thomas
    Klingel, Karin
    Messroghli, Daniel
    Schubert, Stephan
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2022, 357 : 95 - 104
  • [34] Clinical Outcomes of Patients Presenting With Acute Heart Failure and Biopsy-Proven Myocarditis at a Major Academic Center
    Nalbandian, Ani
    Topkara, Veli K.
    Garan, Arthur R.
    CIRCULATION, 2018, 138
  • [35] Survival in biopsy-proven myocarditis: A long-term retrospective analysis of the histopathologic, clinical, and hemodynamic predictors
    Magnani, JW
    Danik, HJS
    Dec, GW
    DiSalvo, TG
    AMERICAN HEART JOURNAL, 2006, 151 (02) : 463 - 470
  • [36] Biopsy-Proven Giant Cell Myocarditis Following the COVID-19 Vaccine
    Sung, Kevin
    McCain, Julia
    King, Kevin R.
    Hong, Kimberly
    Aisagbonhi, Omonigho
    Adler, Eric D.
    Urey, Marcus A.
    CIRCULATION-HEART FAILURE, 2022, 15 (04) : 414 - 417
  • [37] Long-Term Evolution and Prognostic Stratification of Biopsy-Proven Active Myocarditis
    Anzini, Marco
    Merlo, Marco
    Sabbadini, Gastone
    Barbati, Giulia
    Finocchiaro, Gherardo
    Pinamonti, Bruno
    Salvi, Alessandro
    Perkan, Andrea
    Di Lenarda, Andrea
    Bussani, Rossana
    Bartunek, Jozef
    Sinagra, Gianfranco
    CIRCULATION, 2013, 128 (22) : 2384 - 2394
  • [38] Acute hemodynamic effects of metoprolol ± nitroglycerin in patients with biopsy-proven lymphocytic myocarditis
    Popovic, Z
    Miric, M
    Vasiljevic, J
    Sagic, D
    Bojic, M
    Popovic, AD
    AMERICAN JOURNAL OF CARDIOLOGY, 1998, 81 (06): : 801 - 804
  • [39] GA-67 IMAGING IN PATIENTS WITH DILATED CARDIOMYOPATHY AND BIOPSY-PROVEN MYOCARDITIS
    OCONNELL, JB
    HENKIN, RE
    ROBINSON, JA
    SUBRAMANIAN, R
    SCANLON, PJ
    GUNNAR, RM
    CIRCULATION, 1984, 70 (01) : 58 - 62
  • [40] Clinical characteristics and outcomes of biopsy-proven diabetic nephropathy
    Li Zhuo
    Nianrong Zhang
    Guming Zou
    Dapeng Chen
    Wenge Li
    Frontiers of Medicine, 2017, 11 : 386 - 392